Medulan (Diclofenac Sodium)

Diclofenac sodium blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By reducing prostaglandin levels at the site of application, the drug diminishes inflammation, swelling, and pain signals, leading to localized analgesic and anti‑inflammatory effects.

The specific dose and frequency of Medulan are determined by the prescribing healthcare professional based on the severity of the condition, the size of the treatment area, and patient factors. Patients should follow the prescriber’s instructions and the product label carefully.

Safety of topical diclofenac during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Medulan to weigh potential risks and benefits.

To request Medulan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with oral NSAIDs, Medulan delivers diclofenac directly to the skin, which can reduce systemic exposure and lower the risk of gastrointestinal side effects. It is similar in efficacy to other topical NSAIDs such as ibuprofen gel, but individual response and tolerability may vary, so clinicians choose based on patient needs and safety profiles.

Medulan should be stored at room temperature, below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Apply a thin layer of Medulan to the clean, dry skin over the affected area, typically 2–4 times daily as directed by a healthcare professional. Gently rub the gel until it is fully absorbed, and wash hands after application to avoid accidental contact with eyes or mucous membranes.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Systemic absorption can also lead to gastrointestinal bleeding, cardiovascular events, or liver and kidney dysfunction, especially when used over large areas or for prolonged periods.

Medulan should be avoided in individuals with known hypersensitivity to diclofenac or other NSAIDs, those with active skin infections or open wounds at the application site, and patients with a history of severe cardiovascular, gastrointestinal, hepatic, or renal disease unless specifically advised by a physician.